Rhode Island Medical Society

12/06/2021

12/01/2021

download the December 2021 issue of the Rhode Island Medical Journal

11/15/2021

Check out this great conference on November 20th www.integrityce.com/hms2021

11/04/2021

www.integrityce.com/hms2021

10/26/2021

Optimizing LDL-C: Individualizing Treatment Using Statins and Nonstatin Therapy

Course Type: On-Demand Webcourse
Number of Credits: 1
Credit Type: CME/MOC/MIPS
https://cme.rockpointe.com/1058-wbc-optimizing-ldl-c-individualizing-treatment-using-statins-and-nonstatin-therapy

Optimizing LDL-C: Individualizing Treatment Using Statins and Nonstatin Therapy will review how to use the risk assessment tool, the 2018 LDL-C guidelines recommendations including the role of the non-statin agents ezetimibe and PCSK9 inhibitors. Expert faculty will discuss the role of bempedoic acid, an agent recently approved for LDL-C management, as well as results from trials of inclisiran, an agent in late-stage development.

FACULTY

Rachel M. Bond, MD, FACC
System Director, Women’s Heart Health
Dignity Health, Arizona
Chandler, AZ


Ty J. Gluckman, MD, FACC, FAHA
Medical Director, Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute
Providence St. Joseph Health
Portland, OR
Adjunct Faculty, Ciccarone Center for the Prevention of Heart Disease
Johns Hopkins Hospital
Baltimore, MD

________________________________________
PROVIDER
Jointly provided by the Potomac Center for Medical Education Health and Rockpointe

SUPPORTER
This activity is supported by educational funding provided by Amgen and Esperion.

10/25/2021

Congratulations to Dr. L. Anthony Cirillo, MD, FACEP - elected to the ACEP Board of Directors

ACEP board looks to the future.

10/22/2021

https://integrityce.com/2021-hospital-medicine-summit-ce-cme-live-virtual-conference-series/

10/15/2021

Course Type: On-Demand Webcourse
Number of Credits: 1
Credit Type: CME/ANCC/MOC/MIPS

Expires: August 18, 2022

https://www.rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/?utm_source=rp&utm_medium=email&utm_term=1087

The CME program, Nonmelanoma Skin Cancers: Current and Emerging Checkpoint Inhibitors for Treating Advanced Basal Cell and Squamous Cell Carcinomas, will provide oncologists with current guideline-based diagnostic, staging, and treatment strategies for patients with advanced BCC and CSCC as well as how newly approved and agents in development fit into treatment strategies.

FACULTY


Roman Groisberg, MD
Assistant Professor, Medical Oncology
Department of Melanoma and Sarcoma
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ


Max Lenowitz, CRNP
Jefferson Medical Oncology
Philadelphia, PA


Melissa Wilson, MD, PhD
Medical Oncology Fellowship Program Director/Melanoma Program Director
St. Luke’s Cancer Center – St. Luke’s University Health Network
Easton, PA

10/14/2021

RIRX Card!

10/07/2021

www.integrityce.com/hms2021
Very popular Hospital Medicine Summit

09/27/2021

Congratulations to Marc Bialek, Director of Membership at the Rhode Island Medical Society for being recognized by the US Army for his outstanding support and dedication to the future of Army Medicine, the Army and its Soldiers and Families. Great ceremony from the Boston Medical Recruiting Company. Great to see the US Army Surgeon General, Lieutenant General R. Scott Di**le, the 45th Surgeon General of the US Army.

The US Army healthcar recruiters are giant supporters of the Rhode Island Medical Society and all of the specialty societies in the state.